Log in to save to my catalogue

Hyperhomocysteinemia in Adult Patients: A Treatable Metabolic Condition

Hyperhomocysteinemia in Adult Patients: A Treatable Metabolic Condition

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10780827

Hyperhomocysteinemia in Adult Patients: A Treatable Metabolic Condition

About this item

Full title

Hyperhomocysteinemia in Adult Patients: A Treatable Metabolic Condition

Publisher

Switzerland: MDPI AG

Journal title

Nutrients, 2023-12, Vol.16 (1), p.135

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Hyperhomocysteinemia (HHcy) is recognized as an independent risk factor for various significant medical conditions, yet controversy persists around its assessment and management. The diagnosis of disorders afffecting homocysteine (Hcy) metabolism faces delays due to insufficient awareness of its clinical presentation and unique biochemical characte...

Alternative Titles

Full title

Hyperhomocysteinemia in Adult Patients: A Treatable Metabolic Condition

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10780827

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10780827

Other Identifiers

ISSN

2072-6643

E-ISSN

2072-6643

DOI

10.3390/nu16010135

How to access this item